LONDON BROKER RATINGS: Citigroup says 'buy' Next, UBS raises Drax
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More
| Price | 1,593.00p on 04-09-2026 at 18:35:12 |
|---|---|
| Change | -12.00p -0.75% |
| Buy | 1,593.00p |
| Sell | 1,591.00p |
| Last Trade: | Sell 2,727.00 at 1,593.237p |
| Day's Volume: | 365,401 |
| Last Close: | 1,593.00p |
| Open: | 1,600.00p |
| ISIN: | GB00B0LCW083 |
| Day's Range | 1,585.00p - 1,604.00p |
| 52wk Range: | 1,187.00p - 1,865.00p |
| Market Capitalisation: | £3.30b |
| VWAP: | 1,595.2366p |
| Shares in Issue: | 206.97m |
Hikma Pharmaceuticals (HIK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 2,727 | 1,593.237p | SI Trade Suspected SELL Trade |
16:47:05 - 04-Sep-26 |
| Buy* | 1,617 | 1,593.00p | SI Trade |
16:35:23 - 04-Sep-26 |
| Buy* | 917 | 1,593.00p | SI Trade |
16:35:23 - 04-Sep-26 |
| Buy* | 115,645 | 1,593.00p | Suspected BUY Trade |
16:35:23 - 04-Sep-26 |
| Sell* | 128 | 1,591.00p | Automatic Execution |
16:29:50 - 04-Sep-26 |
| Sell* | 57 | 1,591.00p | Automatic Execution |
16:29:50 - 04-Sep-26 |
| Sell* | 184 | 1,591.00p | Automatic Execution |
16:29:50 - 04-Sep-26 |
| Sell* | 1 | 1,591.00p | Automatic Execution |
16:29:50 - 04-Sep-26 |
| Sell* | 333 | 1,591.00p | Automatic Execution |
16:29:50 - 04-Sep-26 |
| Sell* | 10 | 1,591.00p | Automatic Execution |
16:29:50 - 04-Sep-26 |
Hikma Pharmaceuticals (HIK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 2nd Sep 2026 1:45 pm | RNS | Holding(s) in Company |
| 1st Sep 2026 4:13 pm | RNS | Total Voting Rights |
| 28th Aug 2026 7:00 am | RNS | Transaction in Own Shares |
| 24th Aug 2026 3:03 pm | RNS | Director/PDMR Shareholding |
| 24th Aug 2026 10:54 am | RNS | Transaction in Own Shares |
| 17th Aug 2026 3:24 pm | RNS | Holding(s) in Company |
| 17th Aug 2026 2:57 pm | RNS | Holding(s) in Company |
| 17th Aug 2026 1:03 pm | RNS | Transaction in Own Shares |
| 11th Aug 2026 10:49 am | RNS | Director/PDMR Shareholding |
| 10th Aug 2026 10:05 am | RNS | Transaction in Own Shares |